Hiroshima Venture Capital is an institutional investor (Conventional VCs) founded in 1995 and headquartered in Hiroshima, Japan. Hiroshima Venture Capital is a stage agnostic venture capital firm investing in Japan. The firm focuses on technology start-ups engaged in the areas such as FinTech and also in life science start-ups such as BioTech, BioScience. Notable portfolio companies include Moneytree, Tech bureau Lab, Chiome Biosciences, PhoenixBio. Notable portfolio companies: Moneytree, Tech bureau Lab, Chiome Biosciences, PhoenixBio.

Stage

pre-seed, seed, Series A, Series B, growth, pre-IPO, pre-seed, seed, Series A, Series B, growth, pre-IPO

Check size

$3M-$10M

HQ

Hiroshima, Japan

Founded

1995

Website

https://www.h-vc.co.jp/

Twitter

https://twitter.com/hiroshimavc

What they look for

Japan-based (Hiroshima/regional focus), high-growth potential targeting IPO, new technologies/business models, university spinouts, 6-10 year old companies, mid-sized/SMEs/ventures

Preparing to pitch Hiroshima Venture Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.